Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportPoster - Educational Exhibits

Off-label usage of Lu-177 DOTATATE therapy : Challenges and Opportunities for the Theranostician

Ashok Muthukrishnan, Theja Pakala, Shyam Srinivas, Nghi Nguyen, Jan Drappatz, Carl Snyderman, Vikram Gorantla and Nathan Bahary
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 2029;
Ashok Muthukrishnan
1Radiology University of Pittsburgh Pittsburgh PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Theja Pakala
1Radiology University of Pittsburgh Pittsburgh PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shyam Srinivas
1Radiology University of Pittsburgh Pittsburgh PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nghi Nguyen
2UPMC, Department of Radiology Pittsburgh PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Drappatz
1Radiology University of Pittsburgh Pittsburgh PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carl Snyderman
1Radiology University of Pittsburgh Pittsburgh PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vikram Gorantla
3Hematology-Oncology University of Pittsburgh Pittsburgh PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathan Bahary
4Hematology-Oncology University of Pittsburgh Medical Center Pittsburgh PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 62 no. supplement 1 2029

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 18, 2021.

Copyright & Usage 
© 2021

Author Information

  1. Ashok Muthukrishnan1,
  2. Theja Pakala1,
  3. Shyam Srinivas1,
  4. Nghi Nguyen2,
  5. Jan Drappatz1,
  6. Carl Snyderman1,
  7. Vikram Gorantla3 and
  8. Nathan Bahary4
  1. 1Radiology University of Pittsburgh Pittsburgh PA United States
  2. 2UPMC, Department of Radiology Pittsburgh PA United States
  3. 3Hematology-Oncology University of Pittsburgh Pittsburgh PA United States
  4. 4Hematology-Oncology University of Pittsburgh Medical Center Pittsburgh PA United States

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2021 to April 2025

AbstractFullPdf
May 20215700
Jun 20216500
Jul 20213600
Aug 20214500
Sep 20213600
Oct 20215700
Nov 20212900
Dec 20212100
Jan 20222700
Feb 20223400
Mar 20222600
Apr 20222200
May 20223100
Jun 20221900
Jul 20223200
Aug 20222600
Sep 20222000
Oct 20222800
Nov 20221400
Dec 20221600
Jan 20232200
Feb 20231800
Mar 20232600
Apr 20232100
May 20232400
Jun 20231600
Jul 20232300
Aug 20231800
Sep 20231100
Oct 20231400
Nov 2023800
Dec 20231800
Jan 20243100
Feb 20243000
Mar 20241500
Apr 20241800
May 20242800
Jun 20241700
Jul 20244300
Aug 20244700
Sep 20242100
Oct 20242300
Nov 20241500
Dec 20241000
Jan 20253100
Feb 20253000
Mar 20253000
Apr 20252700
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 62, Issue supplement 1
May 1, 2021
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Off-label usage of Lu-177 DOTATATE therapy : Challenges and Opportunities for the Theranostician
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Off-label usage of Lu-177 DOTATATE therapy : Challenges and Opportunities for the Theranostician
Ashok Muthukrishnan, Theja Pakala, Shyam Srinivas, Nghi Nguyen, Jan Drappatz, Carl Snyderman, Vikram Gorantla, Nathan Bahary
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 2029;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Off-label usage of Lu-177 DOTATATE therapy : Challenges and Opportunities for the Theranostician
Ashok Muthukrishnan, Theja Pakala, Shyam Srinivas, Nghi Nguyen, Jan Drappatz, Carl Snyderman, Vikram Gorantla, Nathan Bahary
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 2029;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Poster - Educational Exhibits

  • FDG-PET/CT as the gold standard in assessing recovery of pulmonary function in COVID-19
  • How Pathology Affects Appearance, Features of Invasive Lobular Carcinoma That Every Imaging Physician Should Know
  • A Pictorial Essay of Non Embolic Findings on VQ SPECT
Show more Poster - Educational Exhibits

Oncology

  • Role of PET/CT in the management of multiple myeloma
  • FDG-PET/CT and NaF-PET/CT in the diagnosis and assessment of radiation therapy-induced vascular complications in patients with head and neck cancer
  • 18F-FDG PET/CT manifestations of three Cases of Female Desmoplastic Small Round Cell Tumor
Show more Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire